Overview

Due to the recent success of New Horizons in Amyloidosis, Radcliffe Cardiology are excited to introduce a new 2-day event ‘New Horizons in Cardiomyopathy’ (NHC) in February 2025.  

The event, hosted on Radcliffe Cardiology, will be streamed on Tuesday 25 February - Wednesday 26 February 2025. It promises an interactive and informative experience, updating professionals on cardiac amyloidosis and cardiomyopathy diagnosis and treatment.

Day 1 will focus on hypertrophic cardiomyopathy (HCM), with a detailed exploration of HCM and an emphasis on emerging therapies and management strategies. Day 2 will focus on amyloidosis, providing a comprehensive update on the diagnosis and treatment of cardiac amyloidosis, along with insights into the latest research and clinical practices.

The course directors, Prof Rodney Falk (Brigham and Women’s Hospital, Boston, US), Prof Perry Elliott (University College London, UK), and Prof Marianna Fontana (University College London, UK), will lead a distinguished group of faculty members who are renowned experts in the field of cardiac amyloidosis. The faculty will encompass a diverse range of medical specialties, facilitating a comprehensive, multidisciplinary approach. This approach is designed to encourage collaboration and knowledge-sharing among healthcare professionals, ultimately enhancing the understanding and management of cardiac amyloidosis and cardiomyopathy.

Our aim is to provide a programme to educate healthcare professionals on the evolving management practices in cardiac amyloidosis and cardiomyopathy in an informal and engaging learning environment featuring thought-provoking presentations, cases and practical masterclasses. 

Register now to gain essential insights and strategies on the diagnosis and treatment of cardiac amyloidosis and cardiomyopathy. We look forward to welcoming you.

*New Horizons in Cardiomyopathy’s programme has been submitted to the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) seeking 6 CME points, equating to 6 hours of learning.

Event starts in:

Share this event:

Programme

(Please note this programme is subject to change)

Day 1 - Focus on Cardiomyopathy

2:05 PM - 2:50 PM (GMT)
Presentation and Discussion
Session 1: The Cardiomyopathy Mindset

  • Presentation of Case Study

  • Suspecting Cardiomyopathy

  • Overview of the Diagnostic Pathway



2:50 PM - 4:00 PM (GMT)
Presentation and Discussion
Session 2: The Diagnostic Pathway

  • Ventricular Morphology & Function

  • Additional Tests

  • Phenotyping



4:00 PM - 4:45 PM (GMT)
Presentation and Discussion
Session 3: The Management of Cardiomyopathy

  • Risk Stratification & Prognostic Assessment

  • The General Approach to Management

  • Management of Our Case Study: Hypertrophic Cardiomyopathy Patient




Day 2 - Focus on Amyloidosis

2:05 PM - 3:00 PM (GMT)
Presentation and Discussion
Session 1: Amyloidosis Specific Diagnosis

  • Presentation of Case Study: Clues for Amyloidosis

  • Amyloidosis Specific Investigations

  • Phenotyping & Genotyping

  • Discussion: New Horizons for Diagnosis



3:00 PM - 3:45 PM (GMT)
Presentation and Discussion
Session 2: Phenotypic Management Strategies

  • Managing AL Amyloidosis: What To Do in Relapse

  • Phenotypic ATTR Management



3:45 PM - 4:30 PM (GMT)
Presentation and Discussion
Session 3: The Treatment Horizon

  • Recent Data: Clinical & Real World

  • Key Overview of On-going Trials

  • The Reversal Debate




Course Leadership

Perry Elliott

Perry Elliott
Course Director
University College London, London, UK

more info

Rodney Falk

Rodney Falk
Course Director
Brigham and Women's Hospital, Boston, US

more info

Marianna Fontana

Marianna Fontana
Course Director
University College London, London, UK

more info

Learning Objectives

  • Increase the awareness of at-risk patients

  • Improve understanding of screening procedures

  • Provide guidance on the use of imaging for diagnosis

  • Improve awareness on current and emerging treatment

  • Provide guidance on initiating treatment and managing comorbidities

Target Audience

  • Cardiologists (device implanters, heart failure)

  • Imaging Specialists

  • Electrophysiologists

  • Primary care

  • Haematologists

  • Cardiac Nurse Practitioners

If you're interested in becoming a partner at NHC, please contact sales@radcliffe-group.com

Official Journal

Cardiac Failure Review (CFR) is an international, English language, peer-reviewed journal that publishes articles continually to CFRjournal.com and aims to assist time-pressured physicians to stay abreast of key advances and opinion in the area of heart failure. 

The journal comprises balanced and comprehensive review articles and original research written by leading authorities. The journal provides updates on a range of salient issues to support physicians in developing their knowledge and effectiveness in day-to-day clinical practice.

The journal endeavours to support the continuous medical education of specialist and general cardiologists and disseminate knowledge of the field to the wider cardiovascular community.

Partnership: CFR is the official journal of the Italian Heart Failure Association (ITAHFA).

Journal website: www.cfrjournal.com

CFR Journal

About Radcliffe Cardiology

We are Radcliffe, a knowledge network for the cardiovascular community

We’re here to bring cardiovascular knowledge, insight and innovation to life for clinicians around the world, using our communications and creative expertise, our platforms and connections across the community to help transform theory into practice faster and more effectively.

We bring medical knowledge to life

From great science writing and smart journal editing, the curation of evidence based and peer-reviewed content, to engaging new formats that cut through the noise, we believe that communication is at the heart of great healthcare.

Our work is underpinned by 3 core principles:

  • We build on the best science
  • We work hands-on with our community
  • We bring fresh thinking


Our promise is that we’ll equip you with the latest knowledge and skills you need, to do the best for your patients.

For more information on Radcliffe Cardiology, please visit www.radcliffecardiology.com